Bourgeon Capital Management LLC Invitae Corp Transaction History

Bourgeon Capital Management LLC

  • $520 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022
BUY
$2.13 - $9.01 $3,621 - $15,317
1,700 Added 56.67%
4,700 $11,000
Q4 2021

Jan 31, 2022
BUY
$14.7 - $28.67 $29,400 - $57,340
2,000 Added 200.0%
3,000 $46,000
Q3 2021

Nov 09, 2021
BUY
$24.31 - $33.6 $24,310 - $33,600
1,000 New
1,000 $28,000

Others Institutions Holding NVTA

# of Institutions
21
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Bourgeon Capital Management LLC Portfolio

Follow Bourgeon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bourgeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bourgeon Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email